What is the Cerdelga SPC used for?
Cerdelga (eliglustat) is used for the treatment of adults with Gaucher disease type 1 who have been identified as having a specific CYP2D6 metaboliser status (so dosing can be matched to how their body breaks down the drug). The SPC (Summary of Product Characteristics) is the official prescribing document that sets out approved indications, dosing by metaboliser status, contraindications, and safety information.
What dosing does the Cerdelga SPC specify?
The SPC describes dosing based on CYP2D6 metaboliser status (ultra-rapid, extensive/normal, intermediate, or poor metabolisers) and also highlights dose adjustments needed with interacting medicines. It also includes how to take the dose (timing with food, if applicable) and what to do in specific situations such as missed doses, depending on the SPC text.
What contraindications and warnings are listed in the Cerdelga SPC?
The SPC includes safety restrictions such as when Cerdelga must not be used (for example, in certain genetic/medication interaction scenarios) and key risks that require monitoring. Typical SPC sections cover:
- drug–drug interactions (especially strong inhibitors/inducers affecting CYP2D6 or related pathways)
- heart-related warnings (such as QT interval considerations, where included)
- other precautions tied to tolerability and liver function (as stated in the SPC)
What side effects does the Cerdelga SPC report?
The SPC lists adverse reactions and may also note which events are most clinically important or require action. Commonly, SPCs for medicines like eliglustat include guidance on monitoring and when to stop or modify treatment if certain side effects occur.
Where to find the exact Cerdelga SPC document?
To access the authoritative Cerdelga SPC text (the exact approved wording), check the European Medicines Agency (EMA) product information page for Cerdelga, or the official national regulator medicines portal where the SPC is published.
If you want, tell me which country/regulatory label you mean (EMA / UK / another EU member state) and I can help you locate the correct SPC version and summarise the specific sections you care about (dose, contraindications, interactions, or side effects).